ArticlePeerJ2026
Hyperglycemia 72 h before necrotizing enterocolitis onset and mortality among premature and term infants in Kenya.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Necrotizing enterocolitis (NEC) is a common complication among preterm infants but can also occur in term babies. A potential relationship between the onset of NEC and hyperglycemia has been suggested, but some studies report no association, necessitating further research to clarify the link between the two conditions. This study aimed to determine the proportion of NEC cases with hyperglycemia 72 h before its onset in preterm and term infants, identify clinical factors associated with hyperglycemia in these infants, and investigate the relationship between hyperglycemia and in-hospital mortality. Methods: A retrospective cohort study was conducted at the Aga Khan University Hospital in Nairobi, Kenya. The participants included preterm and term infants treated for NEC at the hospital between January 1, 2014, and December 31, 2024. Patient data were retrieved from the electronic health records and paper files. Random blood sugar records 72 h before the diagnosis of NEC were assessed. Hyperglycemia was diagnosed based on a minimum of two blood glucose measurements exceeding 8.3 mmol/l (150 mg/dl). The study outcomes were proportion of NEC cases with hyperglycemia 72 h before its onset and in-hospital mortality. A generalized linear regression model with binomial probability distribution was used to identify the factors associated with hyperglycemia incidence in neonates diagnosed with NEC. Results: The proportion of NEC cases with hyperglycemia 72 h before its onset in preterm and term infants was 46.3%. Among the participants, 20.9% ( Conclusion: The results show that nearly half (46.3%) of the preterm and term infants with NEC were diagnosed with hyperglycemia 72 h before its onset. The diagnosis of hyperglycemia was not associated with in-hospital mortality. These findings should be validated in larger, adequately powered studies before clinical application.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.